RegenOsteo Orthopedic Beta-TCP 02-050-02-RGO

GUDID 00856509002690

Synthetic bone graft substitute in particulate form composed of beta-tricalcium phosphate intended to fill bony void or gaps of the extremities, posterolateral spine, and pelvis that are caused by trauma or surgery and are not intrinsic to the stability of the bony structure.

CYTOPHIL, INC.

Bone matrix implant, synthetic

• Primary Device ID: 00856509002690
• NIH Device Record Key: a4f7246e-f275-4d9c-86cb-9122620e7711
• Commercial Distribution Discontinuation: 2019-11-07
• Commercial Distribution Status: Not in Commercial Distribution
• Brand Name: RegenOsteo Orthopedic Beta-TCP
• Version Model Number: 02-050-02-RGO
• Catalog Number: 02-050-02-RGO
• Company DUNS: 024222105
• Company Name: CYTOPHIL, INC.
• Device Count: 1
• DM Exempt: false
• Pre-market Exempt: false
• MRI Safety Status: Labeling does not contain MRI Safety Information
• Human Cell/Tissue Product: false
• Device Kit: false
• Device Combination Product: false
• Single Use: true
• Lot Batch: true
• Serial Number: false
• Manufacturing Date: false
• Expiration Date: true
• Donation Id Number: false
• Contains Natural Rubber Latex: false
• Labeled No Natural Rubber Latex: false
• RX Perscription: true
• OTC Over-The-Counter: false

Device Dimensions

• Total Volume: 5 Milliliter

Operating and Storage Conditions

• Storage Environment Temperature: Between 15 Degrees Celsius and 32 Degrees Celsius

Device Identifiers

Device Issuing Agency	Device ID
GS1	00856509002690 [Primary]

FDA Product Code

• MQV: Filler, Bone Void, Calcium Compound

Sterilization

• Steralize Prior To Use: false
• Device Is Sterile: true

Device Entry Metadata

• Public Version Status: Update
• Device Record Status: Published
• Public Version Number: 2
• Public Version Date: 2019-11-08
• Device Publish Date: 2019-10-30

On-Brand Devices [RegenOsteo Orthopedic Beta-TCP]

• 00856509002706: Synthetic bone graft substitute in particulate form composed of beta-tricalcium phosphate intend
• 00856509002690: Synthetic bone graft substitute in particulate form composed of beta-tricalcium phosphate intend